Beaufort CRO
Nancy Maldeis is an experienced project manager and executive in the field of clinical operations and public health. Currently serving as Project Manager at Beaufort CRO since January 2017 and as President & CEO of NEM Consulting LLC since November 2016, Nancy has extensive expertise in clinical development. Previously, Nancy held the roles of Director of Corporate Clinical Development and Director of Worldwide Corporate Clinical Operations at BD from October 2007 to July 2015. Academically, Nancy earned a Doctor of Philosophy (PhD) in Epidemiology/Clinical Trials and a Master of Public Health (MPH) from Johns Hopkins University - Bloomberg School of Public Health, completing the doctoral program in 2007 and the master's program in 2002.
This person is not in any offices
Beaufort CRO
Beaufort is a global CRO built around one purpose — helping life science companies improve and save lives through the rapid development and commercialization of innovative products. Our shared interest and commitment to your success drives our entire organization to deliver best-in-class clinical trial services, regulatory strategy and planning, data and business analytics, data management and statistics, and quality services. We are: ◈ MedTech Focused - Industry-leading expertise to streamline your clinical development. ◈ IVD Specialists - Two decades of extensive diagnostic experience. ◈ Results Oriented - Guided by efficient and adaptive clinical trial management. ◈ Partnership Driven - 94% of clients rate Beaufort higher than other CROs Our experience includes: ◈ 500+ Regulatory Submissions including 510(k)s, PMAs, IDEs and CE-Marks ◈ 4,000+ Clinical Study Sites Around the Globe ◈ 1,000+ Clinical Trials Across a Wide Variety of Indications and Testing Platforms ◈ 2,600+ Clinical Professionals in Over 50 Countries See how Beaufort CRO can accelerate your medical innovation -- and put our experience to work for you.